Clinical Trial: Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional




Official Title: A 90-Day, Randomized, Dose-Ranging Study, Including Potential Dose Titration, Evaluating the Efficacy and Safety of Intranasal TBS-1 in the Treatment of Male Hypogonadism With Sequential Safety Extens

Brief Summary: The purpose of this study is to determine the efficacy (based on the pharmacokinetic profile of testosterone) and safety of TBS-1 in the treatment of hypogonadal men